1.1 List of Tables 4
1.2 List of Figures 5

2 Introduction 6
2.1 Cardiac Resynchronisation Therapy (CRT) Overview 6

3 Products under Development 7
3.1 Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Stage of Development 7
3.2 Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Segment 8
3.3 Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Territory 9
3.4 Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Regulatory Path 10
3.5 Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Estimated Approval Date 11
3.6 Cardiac Resynchronisation Therapy (CRT) - Ongoing Clinical Trials 12

4 Cardiac Resynchronisation Therapy (CRT) - Pipeline Products under Development by Companies 13
4.1 Cardiac Resynchronisation Therapy (CRT) Companies - Pipeline Products by Stage of Development 13
4.2 Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Stage of Development 14

5 Cardiac Resynchronisation Therapy (CRT) Companies and Product Overview 15
5.1 Boston Scientific Corp Company Overview 15
5.1.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 15
5.2 DHS Medical Company Overview 20
5.2.1 DHS Medical Pipeline Products & Ongoing Clinical Trials Overview 20
5.3 EBR Systems Inc Company Overview 22
5.3.1 EBR Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 22
5.4 IRadimed Corp Company Overview 26
5.4.1 IRadimed Corp Pipeline Products & Ongoing Clinical Trials Overview 26
5.5 Johns Hopkins University Company Overview 27
5.5.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 27
5.6 Mayo Clinic Company Overview 28
5.6.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 28
5.7 Medtronic plc Company Overview 29
5.7.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 29
5.8 MicroPort CRM Company Overview 31
5.8.1 MicroPort CRM Pipeline Products & Ongoing Clinical Trials Overview 31
5.9 NewPace Ltd Company Overview 33
5.9.1 NewPace Ltd Pipeline Products & Ongoing Clinical Trials Overview 33
5.10 Odem Medical Ltd Company Overview 34
5.10.1 Odem Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

6 Cardiac Resynchronisation Therapy (CRT)- Recent Developments 35
6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 35
6.2 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 37
6.3 Oct 30, 2019: LivaNova reports third quarter 2019 results 38
6.4 Oct 23, 2019: Boston Scientific announces results for third quarter 2019 39
6.5 Oct 21, 2019: Sean Salmon named executive vice president and group president of Medtronic Diabetes 41

7 Appendix 87
7.1 Methodology 87
7.2 About GlobalData 90
7.3 Contact Us 90
7.4 Disclaimer 90

List of Tables
Table 1: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Stage of Development
Table 2: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Segment
Table 3: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Territory
Table 4: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Regulatory Path
Table 5: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Estimated Approval Date
Table 6: Cardiac Resynchronisation Therapy (CRT) - Ongoing Clinical Trials
Table 7: Cardiac Resynchronisation Therapy (CRT) Companies - Pipeline Products by Stage of Development
Table 8: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Stage of Development
Table 9: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Next Generation Quad Polar CRT-D - Product Status
Table 11: Next Generation Quad Polar CRT-D - Product Description
Table 12: NG3 Non Quad System - Product Status
Table 13: NG3 Non Quad System - Product Description
Table 14: Resonate 2.0 - Product Status
Table 15: Resonate 2.0 - Product Description
Table 16: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 17: Next Generation Quad Polar CRT-D - Heart Failure Indication and Sudden Cardiac Death Prevention Trial Japan
Table 18: DHS Medical Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Drimmer - Product Status
Table 20: Drimmer - Product Description
Table 21: Twistek - Product Status
Table 22: Twistek - Product Description
Table 23: EBR Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Second Generation WiSE CRT System - Product Status
Table 25: Second Generation WiSE CRT System - Product Description
Table 26: WiSE CRT System - Product Status
Table 27: WiSE CRT System - Product Description
Table 28: EBR Systems Inc - Ongoing Clinical Trials Overview
Table 29: WiSE CRT System - Image Optimization and Guidance for Wireless Endocardial Cardiac Resynchronization Therapy: The CT Guided Trial
Table 30: WiSE CRT System - Multicenter, Prospective Evaluation of Safety and Performance of the WiCS-LV System in Patients Indicated for Cardiac Resynchronization Therapy
Table 31: WiSE CRT System - Stimulation of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in Non-responders and Previously Untreatable Patients (SOLVE CRT)
Table 32: IRadimed Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 33: MR Defibrillator - Product Status
Table 34: MR Defibrillator - Product Description
Table 35: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Cardiac Arrhythmia Termination Device - Product Status
Table 37: Cardiac Arrhythmia Termination Device - Product Description
Table 38: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Atrial Fibrillation Device - Product Status
Table 40: Atrial Fibrillation Device - Product Description
Table 41: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 42: MRI Safe CRT-D - Product Status
Table 43: MRI Safe CRT-D - Product Description
Table 44: Next Gen ICD And CRT-D - Product Status
Table 45: Next Gen ICD And CRT-D - Product Description
Table 46: MicroPort CRM Pipeline Products & Ongoing Clinical Trials Overview
Table 47: PARADYM RF SonR CRT-D - Product Status
Table 48: PARADYM RF SonR CRT-D - Product Description
Table 49: Triple-Site Ventricular (Tri-V) Pacing CRT-D - Product Status
Table 50: Triple-Site Ventricular (Tri-V) Pacing CRT-D - Product Description
Table 51: NewPace Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 52: The Implantable Subcutaneous String Defibrillator (ISSD) - Product Status
Table 53: The Implantable Subcutaneous String Defibrillator (ISSD) - Product Description
Table 54: Odem Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 55: Odem Device - Product Status
Table 56: Odem Device - Product Description
Table 57: Glossary

List of Figures
Figure 1: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Stage of Development
Figure 2: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Segment
Figure 3: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Territory
Figure 4: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Regulatory Path
Figure 5: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Estimated Approval Date
Figure 6: Cardiac Resynchronisation Therapy (CRT) - Ongoing Clinical Trials

Companies Mentioned
- Boston Scientific Corp
- DHS Medical
- EBR Systems Inc
- IRadimed Corp
- Johns Hopkins University
- Mayo Clinic
- Medtronic plc
- MicroPort CRM
- NewPace Ltd
- Odem Medical Ltd